CI

At a glance

ClinicalIndex Comparison Record
Phase 4Terminated· 2 enrolled
Drug / intervention
Anti-Arrhythmics +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03035227
NCT03035227Phase 4Terminated
Terminated
CompareCT.gov

Catheter Ablation of Arrhythmias to Improve CRT Response

Kansas City Heart Rhythm Institute·interventional·Posted Jan 27, 2017·Updated Sep 10, 2022

In Brief

A Phase 4 clinical trial evaluating Catheter Ablation and Anti-Arrhythmics for Arrhythmia, Cardiac. Terminated early, enrolled 2 participants across 1 site.

Signals

Trial was terminated early

Detailed Summary

The purpose of this study is to test if catheter ablation is better than medication therapy at treating arrhythmias originating from the upper and/or lower chambers of the heart in order to allow the heart to beat properly.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Cardiac
CountriesUnited States
CollaboratorsBiosense Webster, Inc.

Timeline

Phase 4TerminatedFinished
2017201820192020202120222023202420252026
First PostedJan 27, 2017
Enrollment StartJan 23, 2017
Primary CompletionMay 1, 2018
TodayJul 1, 2026
Enrollment to primary: 1.3 yearsPosted 9.4 years ago

Interventions

Catheter Ablationprocedure

Catheter ablation of atrial or ventricular arrhythmia. The technique and type of ablation will be at the discretion of the treating electrophysiologists.

Anti-Arrhythmicsdrug

Anti-Arrhythmic drugs that are deemed to be appropriate for the given participants's arrhythmia by the treating physician.